Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Esbriet price in philippines?

See the DrugPatentWatch profile for Esbriet

Current Price of Esbriet in the Philippines

As of my knowledge cutoff in 2023, the average retail price of Esbriet (pirfenidone) in the Philippines is around PHP 12,800 to PHP 15,500 per capsule, depending on the supplier and availability.

Comparison with Other Countries

According to DrugPatentWatch.com, Esbriet prices vary significantly across different countries. For example, in the United States, the wholesale acquisition cost is around $44,000 per year, while in Australia, it is approximately AUD 1,800 (PHP 74,000) per year.

Why is Esbriet Expensive?

Esbriet is a proprietary medication developed by Actelion Pharmaceuticals, a subsidiary of Johnson & Johnson. The high price of Esbriet can be attributed to several factors, including its proprietary status, high research and development costs, marketing and sales expenses, and government-imposed price markups.

Availability and Affordability

In the Philippines, Esbriet is available through select hospitals, clinics, and pharmacies, mainly in Metro Manila and key regions. However, the high price may make it inaccessible to many patients, particularly those in lower-income households. To address this concern, local authorities and healthcare providers are exploring options for price negotiation and access programs.

Patent Status and Exclusivity

According to DrugPatentWatch.com, the patent for Esbriet in the Philippines expires in 2027. This could potentially lead to the approval of generic or biosimilar versions of the medication, which may reduce prices and increase accessibility.

Patient Assistance Programs

Some pharmaceutical companies, including Actelion Pharmaceuticals, offer patient assistance programs that provide financial support for patients with limited income. These programs may help patients access Esbriet at a reduced price or even for free.

Sources:

1. DrugPatentWatch.com
2. Actelion Pharmaceuticals. (n.d.). Esbriet. Retrieved from https://www.actelion.com/products/diagnostic-and-therapeutic-products/interstitial-lung-diseases/esbriet/
3. Hospital and clinic websites, providing current prices for Esbriet.



Other Questions About Esbriet :

esbriet תרופה Esbriet clinical trials? Esbriet 801 mg cost? Esbriet 801 mg cost?